Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

[A comparison and significance of plasma riboflavin levels in patients with esophageal squamous cell carcinoma versus Linzhou healthy migrants in Changzhi of Shanxi].

Ji AF, Wei W, Wang JS, Wei ZB, Lian CH, Yang JZ, Zhao L, Ma L, Ma L, Qin XQ, He XF, Wang LD.

Zhonghua Nei Ke Za Zhi. 2011 Dec;50(12):1048-50. Chinese.

PMID:
22333176
2.

[The relationship between C20orf54 gene rs3746804 position single nucleotide polymorphism and susceptibility to esophageal squamous cell carcinoma].

Ji AF, Wei W, Yang JZ, Wang JS, Zhao L, Wei ZB, Lian CH, Ma L, Ma L, Wang HL, Qin XQ, Wang LD.

Zhonghua Nei Ke Za Zhi. 2012 Dec;51(12):982-6. Chinese.

PMID:
23327963
3.

Association of the plasma riboflavin levels and riboflavin transporter (C20orf54) gene statuses in Kazak esophageal squamous cell carcinoma patients.

Ainiwaer J, Tuerhong A, Hasim A, Chengsong D, Liwei Z, Sheyhidin I.

Mol Biol Rep. 2013 May;40(5):3769-75. doi: 10.1007/s11033-012-2453-7. Epub 2012 Dec 30.

PMID:
23275236
4.
5.

Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma.

Wang JY, Zheng YZ, Yang J, Lin YH, Dai SQ, Zhang G, Liu WL.

BMC Cancer. 2012 Aug 23;12:365. doi: 10.1186/1471-2407-12-365.

6.

The association between serum Dickkopf-1 levels and esophageal squamous cell carcinoma.

Begenik H, Kemik AS, Emre H, Dulger AC, Demirkiran D, Ebinc S, Kemik O.

Hum Exp Toxicol. 2014 Aug;33(8):785-8. doi: 10.1177/0960327113510537. Epub 2013 Nov 12.

PMID:
24220876
7.

Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.

Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, Nagata H, Kosuga T, Iitaka D, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Otsuji E.

Br J Cancer. 2011 Jun 28;105(1):104-11. doi: 10.1038/bjc.2011.198. Epub 2011 Jun 14.

8.
9.

Plasma Riboflavin Level is Associated with Risk, Relapse, and Survival of Esophageal Squamous Cell Carcinoma.

Li SS, Xu YW, Wu JY, Tan HZ, Wu ZY, Xue YJ, Zhang JJ, Li EM, Xu LY.

Nutr Cancer. 2017 Jan;69(1):21-28. doi: 10.1080/01635581.2017.1247890. Epub 2016 Nov 29.

PMID:
27898225
10.

Serum markers as predictors of esophageal squamous dysplasia and early cancer.

Chen W, Abnet CC, Wei WQ, Roth MJ, Lu N, Taylor PR, Pan QJ, Luo XM, Dawsey SM, Qiao YL.

Anticancer Res. 2004 Sep-Oct;24(5B):3245-9.

11.

New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma.

Xu SY, Liu Z, Ma WJ, Sheyhidin I, Zheng ST, Lu XM.

Biomarkers. 2009 Aug;14(5):340-6. doi: 10.1080/13547500902903055.

PMID:
19552569
12.

Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma.

Kurashige J, Kamohara H, Watanabe M, Tanaka Y, Kinoshita K, Saito S, Hiyoshi Y, Iwatsuki M, Baba Y, Baba H.

J Surg Oncol. 2012 Aug 1;106(2):188-92. doi: 10.1002/jso.23064. Epub 2012 Feb 21.

PMID:
22354855
13.

[Serum proteomic spectra of esophageal squamous cell carcinoma patients analyzed with IMAC3 protein chip].

Liu CZ, Zhu PY, Shi MX, Liu JB, Liao P, Xiang CQ, Zhang YX, Wang WJ.

Ai Zheng. 2008 Mar;27(3):272-8. Chinese.

PMID:
18334116
14.

Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma.

Wang LS, Chow KC, Li WY, Liu CC, Wu YC, Huang MH.

Clin Cancer Res. 2000 Apr;6(4):1445-51.

15.

Reduced expression of human DNA repair genes in esophageal squamous-cell carcinoma in china.

Liu R, Yin LH, Pu YP.

J Toxicol Environ Health A. 2007 Jun;70(11):956-63.

PMID:
17479411
16.

Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus).

Lukaszewicz-Zając M, Mroczko B, Kozłowski M, Nikliński J, Laudański J, Siewko M, Szmitkowski M.

J Clin Lab Anal. 2012 Feb;26(2):73-81. doi: 10.1002/jcla.21486.

PMID:
22467322
17.

Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers.

Shimada Y, Watanabe G, Kawamura J, Soma T, Okabe M, Ito T, Inoue H, Kondo M, Mori Y, Tanaka E, Imamura M.

Oncology. 2005;68(2-3):285-92. Epub 2005 Jul 7.

PMID:
16015046
18.

Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas.

Ren Y, Cao B, Law S, Xie Y, Lee PY, Cheung L, Chen Y, Huang X, Chan HM, Zhao P, Luk J, Vande Woude G, Wong J.

Clin Cancer Res. 2005 Sep 1;11(17):6190-7.

19.

Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study.

Zhang D, Zhang Q, Zhou L, Huo L, Zhang Y, Shen Z, Zhu Y.

BMC Cancer. 2010 Nov 26;10:650. doi: 10.1186/1471-2407-10-650.

20.

Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus.

Takeuchi H, Ikeuchi S, Kitagawa Y, Shimada A, Oishi T, Isobe Y, Kubochi K, Kitajima M, Matsumoto S.

J Gastroenterol Hepatol. 2007 Dec;22(12):2222-7.

PMID:
18031385

Supplemental Content

Support Center